Thyrotropin-secreting pituitary adenomas (TSH-omas) present with signs and symptoms of
hyperthyroidism and they are characterized by elevated serum levels of free thyroid …

Thyrotoxicosis is the clinical manifestation of excess thyroid hormone action at the tissue
level due to inappropriately high circulating thyroid hormone concentrations …

Background: Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies.
Appropriate treatment requires an accurate diagnosis and is influenced by coexisting …

Giant pituitary adenomas comprise about 6–10% of all pituitary tumors. They are mostly
clinically non-functioning adenomas and occur predominantly in males. The presenting …

Inappropriate secretion of TSH was first described in 1960 in a patient with evidence of
hyperthyroidism and expanded sella on imaging. It was later found that a type of pituitary …

Abstract Thyrotropin (TSH)-secreting adenomas (TSHomas) are the rarest form of pituitary
adenomas, and most endocrinologists will see few cases in a lifetime, if any. In most cases …

Pituitary adenomas are benign tumours comprising approximately 16% of all primary cranial
neoplasms. Functioning pituitary adenomas (prolactinomas, somatotroph, corticotroph …

TSH-secreting pituitary neuroendocrine tumor (PitNET) is one of the causes of central
hyperthyroidism. The incidence of TSH PitNET is far lower than that of other PitNETs. The …

Purpose TSH-secreting pituitary adenomas are rare pituitary tumors. An efficient treatment is
essential to limit the mortality and morbidity in untreated patients. The aim of this study is to …

Normal or elevated thyrotropin (TSH) levels in hyperthyroid patients are characteristic of rare
TSH-secreting pituitary adenoma (TSH-oma), which is easily detectable by computed …